J1920 Labetalol Injection HCPCS Reimbursement

HCPCS Level II code J1920 denotes a 5 mg injection of labetalol hydrochloride, a parenteral antihypertensive used in acute blood pressure management. This supply/drug-injection code matters nationally because it is used across inpatient, outpatient, emergency, and ambulatory settings to bill for a commonly used intravenous or intramuscular antihypertensive agent. Accurate coding affects clinical documentation, inventory management, and reimbursement for acute blood-pressure control therapies.

Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context for labetalol injections and what to expect when this HCPCS Level II code appears on service lines. The publication outlines benchmarks and payment considerations, summarizes relevant coding practice for a parenteral antihypertensive supply, and highlights common billing modifiers and payer considerations where available.

This national-focused summary is intended to help billing managers, revenue cycle professionals, and clinicians recognize the code’s clinical purpose, identify typical sites of service, and locate the content sections that cover benchmarks, payer policy variations, and documentation implications. Data not available in the input will be indicated where applicable.

Billing Code Overview

HCPCS Level II code J1920 describes an injection of labetalol hydrochloride, 5 mg. This code represents a billed supply of a specific dose of labetalol for parenteral administration. The service type is a drug injection/administration supply, and the typical site of service includes hospital inpatient and outpatient settings, emergency departments, and ambulatory care clinics where parenteral antihypertensive therapy is administered.

Data not available in the input.

Clinical Context

A typical patient is an adult presenting to an emergency department, obstetrics unit, or outpatient infusion center with acute hypertension requiring parenteral therapy. For example, a pregnant patient at 34 weeks' gestation with severe-range blood pressures and concern for preeclampsia is assessed by the obstetrics team. After evaluation (vitals, fetal monitoring, laboratory studies), the clinician orders intravenous labetalol for rapid blood pressure control. A registered nurse prepares and administers J1920 (labetalol hydrochloride, 5 mg injection) as part of a titrated dosing schedule. Vital signs, fetal status (if applicable), and any adverse effects (bradycardia, bronchospasm) are monitored. Documentation includes indication, dose(s) administered, route, time, response to therapy, and any concurrent medications. In emergency medicine or general medicine scenarios, similar workflow occurs for acute hypertensive urgencies or urgencies with end-organ risk where rapid IV beta-blockade is indicated.

Coding Specifications

Modifier	Description	When to Use
`25`	Significant, separately identifiable evaluation and management service by the same physician on the same day of the procedure	Use when an E/M visit is performed and is separate from administration of `J1920` (e.g., full clinical exam and decision-making leading to injection).

Taxonomy Code	Specialty	Notes
207RH0000X	Emergency Medicine	Emergency physicians commonly order IV labetalol for acute severe hypertension.
207VG0300X	Obstetrics & Gynecology	OB/GYN physicians manage hypertensive disorders of pregnancy and administer parenteral antihypertensives.
207RC0000X	Internal Medicine	Hospitalists and internists manage inpatient acute hypertension requiring IV therapy.
2084P0800X	Critical Care Medicine	Intensivists administer and titrate IV antihypertensives in critically ill patients.
363L00000X	Nurse Practitioner	Advanced practice providers frequently order and supervise administration of `J1920` in multiple settings.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`I10`	Essential (primary) hypertension	Common indication for parenteral antihypertensive therapy when severe or uncontrolled in urgent settings.
`O13.9`	Gestational hypertension without significant proteinuria, unspecified trimester	Relevant for pregnant patients requiring acute BP control with labetalol.
`O14.1`	Preeclampsia with severe features	Frequent indication for IV labetalol to rapidly lower severe blood pressure in pregnancy.
`I16.0`	Hypertensive urgency	Labetalol used when rapid but controlled blood pressure reduction is needed to prevent end-organ damage.
`I10/I16`	Hypertensive emergency/urgency overlap	Represents clinical scenarios where IV antihypertensives, including labetalol, are used; coders should select the specific emergency code when end-organ damage exists.
`I20.0`	Unstable angina	IV beta-blockade may be required cautiously; labetalol use should be clinically justified.
`J45.909`	Asthma, uncomplicated, unspecified	Use caution with beta-blocker therapy; documents contraindications or monitoring when labetalol administered.
`E11.9`	Type 2 diabetes mellitus without complications	Common comorbidity affecting monitoring and medication selection during acute BP management.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`96372`	Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular	May be used if labetalol is administered IM in settings where IV access is not available; documents injection procedure separate from drug J-code.
`96365`	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	Used when labetalol is given as an initial continuous IV infusion rather than bolus injections; documents infusion administration.
`99024`	Postoperative follow-up visit, included in global service	May be referenced when follow-up after a procedure or hospitalization includes review of blood pressure control after `J1920` use.
`93000`	Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report	Often performed before or after administration of IV beta-blocker in patients with cardiovascular disease to monitor for conduction changes.
`36415`	Collection of venous blood by venipuncture	Used for laboratory monitoring (electrolytes, renal function, liver tests) before/after administration of parenteral labetalol.

OpenPayer

Summary & Overview

HCPCS J1920: Labetalol Hydrochloride Injection, 5 mg